Group One Trading
DNLI icon

Group One Trading’s Denali Therapeutics DNLI Stock Holding History

Group One Trading’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$108K Buy
5,600
+5,500
+5,500% +$109K ﹤0.01% 4654
2025
Q4 		$1.65K Hold
100
– – ﹤0.01% 7608
2025
Q3 		$1.45K Buy
+100
New +$1.44K ﹤0.01% 7987
2024
Q4 		– Sell
-1,900
Closed -$55.3K – 7415
2024
Q3 		$55.3K Buy
1,900
+300
+19% +$7.44K ﹤0.01% 4599
2024
Q2 		$37.2K Buy
1,600
+1,100
+220% +$21.1K ﹤0.01% 4752
2024
Q1 		$10.3K Buy
+500
New +$9.4K ﹤0.01% 5847
2023
Q4 		– Sell
-200
Closed -$4.13K – 7552
2023
Q3 		$4.13K Sell
200
-400
-67% -$10.1K ﹤0.01% 6791
2023
Q2 		$17.7K Sell
600
-78,000
-99% -$2.19M ﹤0.01% 6063
2023
Q1 		$1.81M Buy
+78,600
New +$2.16M 0.01% 1616
2022
Q3 		– Sell
-1,300
Closed -$38K – 7662
2022
Q2 		$38K Sell
1,300
-4,900
-79% -$128K ﹤0.01% 5788
2022
Q1 		$199K Sell
6,200
-18,500
-75% -$637K ﹤0.01% 4806
2021
Q4 		$1.1M Buy
+24,700
New +$1.17M ﹤0.01% 3262
2021
Q3 		– Sell
-300
Closed -$24K – 8285
2021
Q2 		$24K Buy
+300
New +$18.6K ﹤0.01% 7072
2021
Q1 		– Sell
-500
Closed -$42K – 7658
2020
Q4 		$42K Sell
500
-700
-58% -$42.3K ﹤0.01% 5119
2020
Q3 		$43K Buy
1,200
+1,100
+1,100% +$33.1K ﹤0.01% 4727
2020
Q2 		$2K Buy
+100
New +$2.35K ﹤0.01% 5546
2019
Q4 		– Sell
-1,100
Closed -$17K – 5198
2019
Q3 		$17K Buy
+1,100
New +$21K ﹤0.01% 4399
2019
Q2 		– Sell
-100
Closed -$2K – 5033
2019
Q1 		$2K Hold
100
– – ﹤0.01% 4580
2018
Q4 		$2K Buy
+100
New +$1.81K ﹤0.01% 4650

Other funds holding DNLI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Group One Trading's DNLI Position: Q4 2024 in Review

Group One Trading sold out of Denali Therapeutics (DNLI) in Q4 2024, closing a stake of 1,691 shares — an estimated $43.3K sold.

Group One Trading first reported a position in DNLI in Q4 2018 and held it in 10 quarters. The position peaked at $1.15M in Q1 2023. 223 funds tracked by Wall St. Rank hold DNLI as of Q4 2024.

  • Group One Trading reported no remaining Denali Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Group One Trading sold 1,691 Denali Therapeutics shares in Q4 2024, an estimated $43.3K.
  • Group One Trading first reported a position in Denali Therapeutics in Q4 2018 and held it in 10 quarters.
  • Group One Trading's Denali Therapeutics position peaked at $1.15M in Q1 2023.
  • 223 funds tracked by Wall St. Rank held Denali Therapeutics as of Q4 2024.

Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.